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Background
Antigen escape tumor cell variants prevail in tumors
recurring after treatment with chimeric antigen receptor
(CAR) T cells with a single specificity. Recurrent tumors
preserve alternative non-targeted tumor associated
antigens.
Hypothesis
A bispecific CAR will mitigate antigen escape enhancing
the antitumor activity of T cells.
Methods and results
HER2 and IL13Ra2 are currently targeted in Phase I
glioblastoma (GBM) trials using CAR T cells. We cre-
ated a bispecific CAR molecule with a HER2-specific
scFv joined in tandem to an IL13Ra2-binding moiety in
the CAR exodomain (Tandem CAR) and a CD28.ζ sig-
naling endodomain. We used computational modeling
to interrogate this design. GBM patients’ Tandem CAR
T cells showed distinct binding to soluble HER2 and
IL13Ra2 and killed primary autologous GBM cells.
Three-dimensional reconstitution and quantification of
confocal images of the Tandem CAR T cell/tumor inter-
face revealed enhanced bifunctional immunological
synapses compared to conventional CARs. Further, Tan-
dem CAR T cells exhibited significantly enhanced inex-
haustible activation dynamics when compared to
conventional HER2 or IL13Ra2 CAR T cells and better
controlled established GBM in an orthotopic murine
model by offsetting both HER2 and IL13Ra2 escape.
Conclusion
Tandem chimeric antigen receptors enhance T cell acti-
vation and mitigate antigen escape through bifunctional
immunological synapse formation in GBM.
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